UPB Competitors & Alternatives
Compare Upstream Bio, Inc. with similar stocks in the same industry
Biotechnology
UPB
Main Stock$6.10
Tradestie Score
43
Market Cap
$1.00B
Revenue Growth
0.8%
Analyst Upside
+582.4%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$10.97
|
$386.68M | - | 54 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$6.41
|
$382.04M | - | 46 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$9.85
|
$371.64M | - | 55 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$25.80
|
$357.51M | - | 55 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$13.70
|
$354.45M | - | 49 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$28.42
|
$353.70M | - | 56 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.64
|
$350.98M | - | 51 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.61
|
$341.56M | - | 55 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$4.71
|
$332.96M | - | 53 | Compare |
|
REPL
Replimune Group, Inc.
|
$8.88
|
$328.62M | - | 60 | Compare |
More UPB Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry